The largest database of trusted experimental protocols

Aptima sars cov 2 on the panther system

Manufactured by Hologic

The Aptima SARS-CoV-2 assay on the Panther system is a diagnostic test for the detection of SARS-CoV-2, the virus that causes COVID-19. The test utilizes nucleic acid amplification technology to identify the presence of the virus in patient samples.

Automatically generated - may contain errors

2 protocols using aptima sars cov 2 on the panther system

1

SARS-CoV-2 RNA Testing Platforms

Check if the same lab product or an alternative is used in the 5 most similar protocols
During the study period, the Henri Mondor hospital virology laboratory used several platforms for SARS-CoV-2 RNA testing, based on technical developments and reagent availability. Between March and June 2020, samples were tested using an in-house RT-qPCR assay based on the Charité protocol targeting the E and RNA-dependent RNA polymerase (RdRp) genes (16 (link)) and on a commercially available RT-PCR assay targeting the E and S genes (RealStar SARS-CoV-2 RT PCR kit 1.0; Altona Diagnostics GmbH, Hamburg, Germany) (17 (link)). After September 2020, SARS-CoV-2 RNA was detected by means of commercially available molecular biology technologies, including TMA (Aptima SARS CoV-2 on the Panther system; Hologic, Marlborough, MA) or RT-PCR (Alinity m; Abbott Molecular, Des Plaines, IL). Samples found to be RNA positive in TMA were retested by RT-PCR (TaqPath COVID-19 RT-PCR kit; Thermo Fisher, Pleasanton, CA) to measure CT values. Samples with CT values above 40 were considered negative.
+ Open protocol
+ Expand
2

SARS-CoV-2 RNA Detection Methods

Check if the same lab product or an alternative is used in the 5 most similar protocols
During the study period, the Henri Mondor hospital virology laboratory used several platforms for SARS-CoV-2 RNA testing, based on technical developments and reagent availability. Between March and June 2020, samples were tested using an in-house RT-qPCR assay based on the Charité protocol targeting the E and RNA-dependent RNA polymerase (RdRp) genes (16 (link)) and on a commercially available RT-PCR assay targeting the E and S genes (RealStar SARS-CoV-2 RT PCR kit 1.0; Altona Diagnostics GmbH, Hamburg, Germany) (17 (link)). After September 2020, SARS-CoV-2 RNA was detected by means of commercially available molecular biology technologies, including TMA (Aptima SARS CoV-2 on the Panther system; Hologic, Marlborough, MA) or RT-PCR (Alinity m; Abbott Molecular, Des Plaines, IL). Samples found to be RNA positive in TMA were retested by RT-PCR (TaqPath COVID-19 RT-PCR kit; Thermo Fisher, Pleasanton, CA) to measure CT values. Samples with CT values above 40 were considered negative.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!